mizoribine has been researched along with Cytomegalovirus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, J; Hatakeyama, S; Mieno, M; Okumi, M; Omoto, K; Shirakawa, H; Tanabe, K; Wakai, S | 1 |
| Daikoku, T; Eizuru, Y; Kanda, Y; Kuramoto, T; Miyawaki, T; Oshima, K; Shiraki, K; Takemoto, M; Yoshida, Y | 1 |
| Ishibashi, M; Kokado, Y; Okuno, T; Shiraki, K; Sonoda, T; Takahara, S; Takahashi, M; Yamanishi, K | 1 |
3 other study(ies) available for mizoribine and Cytomegalovirus
| Article | Year |
|---|---|
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients.
Topics: Adult; Antibodies, Monoclonal; Antiviral Agents; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Recombinant Fusion Proteins; Retrospective Studies; Ribonucleosides; Risk Factors; Rituximab; Tacrolimus; Tissue Donors; Treatment Outcome | 2017 |
Novel anticytomegalovirus activity of immunosuppressant mizoribine and its synergism with ganciclovir.
Topics: Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Drug Resistance, Viral; Drug Synergism; Ganciclovir; Guanine; Guanosine; Humans; Immunosuppressive Agents; Mutation; Ribonucleosides; Viral Plaque Assay | 2010 |
Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus.
Topics: Azathioprine; Cell Line; Cyclosporins; Cytomegalovirus; Embryo, Mammalian; Humans; Immunosuppressive Agents; Kinetics; Prednisolone; Ribonucleosides; Virus Replication | 1990 |